Cupid reports strong Q2 profit jump and raises financial year targets

Cupid shares are expected to attract investor attention after the company announced that its second-quarter net profit more than doubled, prompting an upward revision of its future revenue and profit targets.

Strong Numbers

For the quarter ending in FY27, Cupid recorded a 133 percent jump in net profit to ₹56.22 crore compared to ₹24.13 crore during the same period last year. In the first half of the fiscal year, net profit surged by 156 percent to reach ₹100.37 crore. Revenue from operations grew 122 percent in the second quarter to ₹187.86 crore, while first-half revenue rose 137 percent to ₹342.58 crore. Earnings before interest, taxes, depreciation, and amortization for the first half stood at ₹114.83 crore.

Growth Drivers

Domestic consumer healthcare and fast-moving consumer goods drove the strong financial performance. The domestic market brought in ₹224.64 crore, making up 67 percent of first-half sales, with the consumer healthcare and FMCG segment alone contributing ₹166.88 crore. International operations contributed ₹112.73 crore, supported by institutional demand through the PFSCM agreement and supplies for South Africa's national programme.

Retail Partnerships

Cupid is expanding its domestic reach through organized retail channels. On November 4, 2026, the company signed a long-term exclusive partnership with V2 Retail. It is also scaling up its collaboration with Style Baazar, aiming to place its products in over 290 stores while anticipating that retailer's network to exceed 500 stores in the next two to three years. This partnership is expected to bring in about ₹200 crore in FY27 and scale past ₹500 crore in coming years.

Updated Outlook

Backed by its strong performance, Cupid raised its FY27 revenue guidance to at least ₹880 crore and net profit guidance to ₹275 crore or more, up from earlier estimates of ₹600 crore in revenue and ₹180 crore in net profit. For FY28, the company projects revenue of at least ₹1,305 crore and net profit of ₹390 crore. For FY29, it expects revenue to cross ₹1,950 crore with a net profit of around ₹605 crore.

Context

Strong corporate earnings reports and raised future guidance often influence market sentiment and stock prices for growing companies. Companies in the consumer healthcare and FMCG sectors frequently expand their market reach by partnering with major retail store chains.